Tepmetko 225 mg – DIN 02516322
Tepmetko is Tepotinib Hydrochloride 225 mg (tablet), sold in Canada. It is supplied by Emd Serono, A Division of Emd Inc., Canada. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Tepotinib Hydrochloride 225 mg
- Brand
- Tepmetko
- Strength
- 225 mg
- Form
- Tablet
- Manufacturer
- Emd Serono, A Division of Emd Inc., Canada
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02516322
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Tepotinib Hydrochloride used for?
Tepotinib Hydrochloride is a cancer medicine (kinase inhibitor).
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
TEPMETKO is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations.
From the FDA-approved label on DailyMed (published Apr 22, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02516322.
- It names Tepmetko, Tepotinib Hydrochloride 225 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Tepmetko by Emd Serono, A Division of Emd Inc., Canada.
In Canada: prescription only.
Ingredients
Active: Tepotinib (Tepotinib Hydrochloride)